tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Li Watsek, 61 are a BUY (95.31%), 3 are a HOLD (4.69%).
Analyst Li Watsek, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 20.5% that have a potential upside of 45.15% achieved within 87 days.
Li Watsek’s has documented 120 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALXO, Alx Oncology Holdings at 29-May-2024.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 8/3/2021. The price target of $5 was fulfilled within 45 days with a profit of $2.9 (138.1%) receiving and performance score of 30.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
3 months 25 days ago
1/4 (25%)
$2.36 (143.90%)
45
Buy
12
$9.82 (450.46%)
10
1 years 16 days ago
1/3 (33.33%)
$9.03 (304.04%)
216
Hold
3.5
$1.32 (60.55%)
3.5
1 years 1 months 10 days ago
5/7 (71.43%)
$1.26 (56.25%)
302
Buy
8
$6.54 (447.95%)
2 years 7 months 25 days ago
0/1 (0%)
$4.69 (141.69%)
Buy
5
3 years 9 months 21 days ago
2/4 (50%)
$2.85 (132.56%)
313
Which stock is Li Watsek is most bullish on?
Which stock is Li Watsek is most reserved on?
What Year was the first public recommendation made by Li Watsek?
